Both of these processes are therefore accelerated towards degeneration in disease processes wherein S100B is increased, notably, Alzheimer's disease (AD) and Down syndrome (DS).In order to study the role of S100B in this context, we have examined S100B overexpressing transgenic mice. The gene discussed is S100B; the disease is Down syndrome.